Circular RNA (circRNA) in Alzheimer's disease (AD)

By Walter J. Lukiw. Frontiers in Genetics, 2013

603 citations recorded by the source corpus.

Circular RNAs (circRNAs) are a naturally occurring family of noncoding RNAs (ncRNAs) highly represented in the eukaryotic transcriptome. Recently characterized, traditional methods of RNA detection and analysis requiring a free 5′ or 3′ ribonucleotide terminus may have significantly underestimated circRNA abundance and significance in eukaryotic cells (Salzman et al., 2012; Wilusz and Sharp, 2013; unpublished observations). Intrinsically resistant to exonucleolytic RNA decay, circRNAs appear to be enriched in mammalian brain tissues (Hansen et al., 2013; Memczak et al., 2013). Interestingly, specific ncRNAs such as the evolutionary ancient microRNA-7 (miRNA-7; chr 9q21.32; an important post-transcriptional regulator of human brain gene expression), are not only highly abundant in human brain, but are also associated with a circRNA for miRNA-7 (ciRS-7), in the same tissues; ciRS-7 contains multiple, tandem anti-miRNA-7 sequences (Burmistrova et al., 2007; Hansen et al., 2013; Lukiw et al., 2013). ciRS-7 thereby acts as a kind of endogenous, competing, anti-complementary miRNA “sponge” to adsorb, and hence quench, normal miRNA-7 functions. Using Northern blot hybridization techniques and the circularity-sensitive circRNA probe RNaseR we here provide initial evidence of a mis-regulated miRNA-7-circRNA system in the sporadic Alzheimer's disease (AD) hippocampal CA1 region (Figure (Figure1).1). Deficits in ciRS-7, and ciRS-7 “sponging activities” might be expected to increase ambient miRNA-7 levels in AD-affected brain cells, as is observed, to ultimately contribute to the down-regulation of selective miRNA-7-sensitive messenger RNA (mRNA) targets (Cogswell et al., 2008; unpublished observations). The presence of up-regulated miRNA-7, due to a deficiency in ciRS-7 “sponging” effects, has high probability to down-regulate AD-relevant targets, such as, for example, the ubiquitin protein ligase A (UBE2A; miRNA-7-UBE2A mRNA energy of association, EA = −22.86 kcal/mol). UBE2A, an autophagic, phagocytic protein essential in the clearance of amyloid peptides in AD and other progressive inflammatory degenerations of the human CNS, is depleted in AD brain (Bingol and Sheng, 2011; Lonskaya et al., 2013). Such miRNA-mRNA regulatory systems mediated by a family of cell- and/or tissue-enriched circRNAs may represent another important layer of epigenetic control over gene expression in health and disease. Indeed, technological advancement and recent discoveries in the field of ncRNAs continue to challenge our basic doctrines of nucleic acid biochemistry and evolutionary biology. Deficits in other circRNA-mediated “miRNA sponging systems” and ambient up-regulation of specific inducible miRNAs may help explain the widely observed, generalized and progressive down-regulation of gene expression that is characteristic of the sporadic AD brain (Loring et al., 2001; Colangelo et al., 2002; Ginsberg et al., 2012; Lukiw, 2013). Figure 1 (A) Detection of circRNA for miRNA-7 (ciRS-7) in sporadic Alzheimer's disease (AD) and age-matched control hippocampal CA1 [control (C) N = 4; AD (A) N = 6]; the single upper ciRS-7 (~1400 nt) band contains ~70 selectively conserved miRNA-7 binding sites ...

Subfields: Cancer Research, Molecular Biology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/8c30afd03030a6e39c4cab087dcff5d5c7f3b003

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Molecular Biology

In Rheumatology

Citations in the corpus

circRNA biogenesis competes with pre-mRNA splicing. (2014, background): “In support of this idea, reduced levels of CDR1as/ciRS-7 circRNA have already been reported in patients suffering from Alzheimer’s disease (Lukiw, 2013).”
Circular RNA and its mechanisms in disease: From the bench to the clinic. (2018, neutral): “It was thus predicted that ciRS-7 deficiency might result in decreased expression of selective miR-7 targets, such as the AD-relevant target UBE2A, via the abovementioned “miRNA sponge” function (Lukiw, 2013).”
CircRNA: a novel type of biomarker for cancer (2017, background): “Furthermore, it is also shown that CDR1as may be connected with Parkinson’s disease, Alzheimer’s disease (AD) and brain development [21, 39, 40].”
Circular RNAs: diversity of form and function (2014, background): “Additionally, this circRNA is less abundant in sporadic Alzheimer’s disease CA1 hippocampal regions relative to agematched controls (Lukiw 2013).”
Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression (2017, background): “circRNAs have been recently verified to be involved in developmental processes, regulation of cell function, pathogenesis of heart diseases, and development of neurodegenerative diseases like Alzheimer’s disease.((5)) In the study of carcinogenesis and progression, just like the extensive involvemen”